Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Anal Neoplasm · Lassa Fever · INO

INOVIO Pharmaceuticals

INOVIO PHARMACEUTICALS, INC.

INOVIO Pharmaceuticals trial registry — 54 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US HQ
203 Employees
Public company Type
INO · NYSE Ticker
Company details
Status
Public
HQ
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US
Employees
203
Programs
46
Drugs
8
Patents
75
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

INOVIO Pharmaceuticals clinical trials

Registry index of 54 ClinicalTrials.gov studies linked to INOVIO Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

INOVIO Pharmaceuticals trial registry — 54 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for INOVIO Pharmaceuticals.

  1. INO-1800 — Phase 1

    Clinical update

  2. 2mg INO-5150 and electroporation device CELLECTRA®-5P — Phase 1

    Clinical update

  3. VGX-3100 — Phase 2

    Clinical update

  4. VGX 3100 — Phase 2

    Clinical update

  5. p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine — Phase 2

    Clinical update

  6. Medpulser Electroporation with Bleomycin — Phase 3

    Clinical update

  7. Medpulser electroporation with Bleomycin — Approved

    Clinical update

  8. MedPulser Electroporation with bleomycin — Approved

    Clinical update

Trial registry

54 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.